导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 10.06% | 106/354 |
| 近一周 | -2.12% | 152/356 |
| 近一月 | -3.98% | 208/362 |
| 近一季 | -5.95% | 218/362 |
| 近半年 | 16.09% | 67/358 |
| 近一年 | 12.96% | 99/349 |
| 近两年 | 39.83% | 97/314 |
| 近三年 | 76.81% | 34/244 |
| 成立以来 | 745.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.47% 226/360 |
25.34% 44/366 |
- - |
- - |
| 2025 | 16.99% 189/358 |
-8.44% 285/340 |
17.15% 32/348 |
7.87% 187/354 |
1.11% 110/358 |
| 2024 | 25.91% 38/329 |
8.64% 53/280 |
8.03% 58/310 |
0.21% 240/318 |
7.06% 30/329 |
| 2023 | 54.76% 5/275 |
18.51% 20/205 |
20.50% 11/230 |
-3.87% 109/262 |
12.73% 45/276 |
| 2022 | -27.06% 129/201 |
-9.62% 91/153 |
-18.36% 134/164 |
0.64% 25/189 |
-1.77% 167/202 |
| 2021 | 23.19% 31/150 |
2.03% 137/312 |
9.24% 72/328 |
1.22% 40/358 |
9.19% 36/151 |
| 2020 | 36.73% 16/103 |
-9.79% 118/280 |
29.66% 37/295 |
8.18% 63/299 |
8.06% 153/305 |
| 2019 | 39.04% 6/88 |
13.92% 61/258 |
5.74% 26/268 |
3.72% 46/253 |
11.28% 46/266 |
| 2018 | 3.45% 8/79 |
- - |
- - |
- - |
-17.23% 192/241 |
| 2017 | 23.51% 21/69 |
- - |
- - |
- - |
- - |
| 2016 | 12.71% 13/59 |
- - |
- - |
- - |
- - |
| 2015 | 14.57% 4/49 |
- - |
- - |
- - |
- - |
| 2014 | 17.15% 7/99 |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 南方恒生生物科技ETF(QDII) | 1.1206 | 25.14% |
| 华宝标普油气上游股票美元A | 0.1538 | 24.94% |
| 广发中证香港创新药ETF发起式联接(QDII)A | 1.3401 | 24.24% |
| 国泰纳斯达克100ETF VS. 建信富时100指数(QDII)人民币A(539003) |